Additionally, GSK-3β is known to be involved in neurodevelopment and synaptic plasticity; its dysregulation can impact dopamine signaling and is implicated in the clinical manifestations of ADHD [16,17]. The gene discussed is GSK3B; the disease is attention deficit-hyperactivity disorder.